rs946461494
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_004484.4(GPC3):c.1296C>T(p.Tyr432Tyr) variant causes a synonymous change. The variant allele was found at a frequency of 0.0000134 in 1,195,627 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0000093 ( 0 hom., 0 hem., cov: 20)
Exomes 𝑓: 0.000014 ( 0 hom. 5 hem. )
Consequence
GPC3
NM_004484.4 synonymous
NM_004484.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.31
Publications
0 publications found
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
- Simpson-Golabi-Behmel syndromeInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Simpson-Golabi-Behmel syndrome type 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.039).
BP6
Variant X-133661847-G-A is Benign according to our data. Variant chrX-133661847-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 476646.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000138 (15/1088220) while in subpopulation MID AF = 0.000487 (2/4106). AF 95% confidence interval is 0.0000857. There are 0 homozygotes in GnomAdExome4. There are 5 alleles in the male GnomAdExome4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High Hemizygotes in GnomAdExome4 at 5 XL gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GPC3 | NM_004484.4 | c.1296C>T | p.Tyr432Tyr | synonymous_variant | Exon 6 of 8 | ENST00000370818.8 | NP_004475.1 | |
| GPC3 | NM_001164617.2 | c.1365C>T | p.Tyr455Tyr | synonymous_variant | Exon 7 of 9 | NP_001158089.1 | ||
| GPC3 | NM_001164618.2 | c.1248C>T | p.Tyr416Tyr | synonymous_variant | Exon 6 of 8 | NP_001158090.1 | ||
| GPC3 | NM_001164619.2 | c.1134C>T | p.Tyr378Tyr | synonymous_variant | Exon 5 of 7 | NP_001158091.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000931 AC: 1AN: 107407Hom.: 0 Cov.: 20 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
107407
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000109 AC: 2AN: 183414 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
183414
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000138 AC: 15AN: 1088220Hom.: 0 Cov.: 28 AF XY: 0.0000141 AC XY: 5AN XY: 354240 show subpopulations
GnomAD4 exome
AF:
AC:
15
AN:
1088220
Hom.:
Cov.:
28
AF XY:
AC XY:
5
AN XY:
354240
show subpopulations
African (AFR)
AF:
AC:
0
AN:
26212
American (AMR)
AF:
AC:
0
AN:
35142
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19282
East Asian (EAS)
AF:
AC:
0
AN:
30064
South Asian (SAS)
AF:
AC:
0
AN:
53942
European-Finnish (FIN)
AF:
AC:
0
AN:
40333
Middle Eastern (MID)
AF:
AC:
2
AN:
4106
European-Non Finnish (NFE)
AF:
AC:
11
AN:
833443
Other (OTH)
AF:
AC:
2
AN:
45696
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00000931 AC: 1AN: 107407Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 29877 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
107407
Hom.:
Cov.:
20
AF XY:
AC XY:
0
AN XY:
29877
show subpopulations
African (AFR)
AF:
AC:
1
AN:
29383
American (AMR)
AF:
AC:
0
AN:
9762
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2608
East Asian (EAS)
AF:
AC:
0
AN:
3419
South Asian (SAS)
AF:
AC:
0
AN:
2325
European-Finnish (FIN)
AF:
AC:
0
AN:
5383
Middle Eastern (MID)
AF:
AC:
0
AN:
234
European-Non Finnish (NFE)
AF:
AC:
0
AN:
52189
Other (OTH)
AF:
AC:
0
AN:
1438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Simpson-Golabi-Behmel syndrome type 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Wilms tumor 1 Benign:1
Oct 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.